Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

The Research-Grade Truth About Follistatin-344 vs Sermorelin

Here's the honest answer: comparing these peptides directly is a category error. It's like asking whether a PCR thermocycler is 'better' than a flow cytometer. Both are essential research tools, but they measure entirely different things. Follistatin-344 remov

This comparison does not assign a generated winner or score.

  • Here's the honest answer: comparing these peptides directly is a category error. It's like asking whether a PCR thermocycler is 'better' than a flow cytometer. Both are essential research tools, but they measure entirely different things. Follistatin-344 removes a biological brake (myostatin) on muscle growth; Sermorelin presses a biological accelerator (GH secretion) on systemic metabolism. Neither replicates the other's effects. The research literature consistently shows that follistatin produces muscle hypertrophy even in GH-deficient states, and Sermorelin improves body composition even when myostatin is unchanged. Investigators who frame this as a competition fundamentally misunderstand peptide pharmacology. The correct research question isn't 'which is better'. It's 'which mechanism am I investigating?' Answer that, and the peptide choice becomes obvious.
  • Real Peptides synthesizes both compounds through small-batch processes with exact amino acid sequencing, ensuring purity and consistency for research institutions requiring reproducible results across studies.
  • The distinction between follistatin-344 vs sermorelin which better comparison isn't about superiority. It's about specificity. Researchers investigating muscle fiber regulation at the genetic level choose follistatin; those examining hormonal restoration and metabolic aging choose Sermorelin. Both mechanisms matter in biological research; neither subsumes the other. If the research question involves how myostatin limits muscle mass, follistatin is the tool. If it involves how declining GH contributes to sarcopenia or metabolic syndrome, Sermorelin is the answer. The peptides coexist in the research toolkit for exactly this reason. They address non-overlapping biological questions with equal precision.
More references

Related material

Comparison

Route Comparison Summary

Intravenous (IV) 100% Immediate PK studies, acute GH response studies Subcutaneous (SC) ~40-70% 5-10 minutes Standard animal model studies Intranasal Low Variable Delivery route c…

View details →
Comparison

Summary Comparison Table

Receptor GHRHR GHS-R1a Mechanism Gs/cAMP Gq/PKC/Ca²⁺ Half-life (rat) ~2 hours ~30-40 min GH Pattern Pulsatile Sustained Moderate DPP-IV Susceptible Resistant N/A FDA status Resear…

View details →